Pasithea Therapeutics (KTTA) Non-Current Assets (2021 - 2024)
Pasithea Therapeutics (KTTA) has disclosed Non-Current Assets for 4 consecutive years, with $8.9 million as the latest value for Q3 2024.
- Quarterly Non-Current Assets fell 10.39% to $8.9 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $36.5 million through Sep 2024, down 13.12% year-over-year, with the annual reading at $9.4 million for FY2023, 15.12% down from the prior year.
- Non-Current Assets hit $8.9 million in Q3 2024 for Pasithea Therapeutics, down from $9.0 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $11.1 million in Q4 2022 to a low of $8570.0 in Q3 2021.
- Historically, Non-Current Assets has averaged $6.8 million across 4 years, with a median of $9.0 million in 2024.
- Biggest five-year swings in Non-Current Assets: soared 59863.97% in 2022 and later decreased 15.7% in 2024.
- Year by year, Non-Current Assets stood at $20124.0 in 2021, then soared by 55074.9% to $11.1 million in 2022, then decreased by 15.12% to $9.4 million in 2023, then decreased by 6.01% to $8.9 million in 2024.
- Business Quant data shows Non-Current Assets for KTTA at $8.9 million in Q3 2024, $9.0 million in Q2 2024, and $9.2 million in Q1 2024.